Come Join Celgene's Clinical Nurse Consultants (CNC) organization! CNCs function as a Registered Nurse (RN) or an Advanced Practice Provider (APP) delivering direct patient care to Hematology Oncology patients. CNCs are clinical subject matter experts, identifying opportunities to create disease awareness and provide disease state education and safety related patient management programs related to the current hematology/oncology portfolio and relevant future disease states. Celgene CNCs educate HCPs, Patients and Caregivers through Patient Support Groups, external collaborating or co-promotion partners, internal cross functional colleagues and field-based sales professionals.
Through peer to peer engagements, Celgene CNCs:
Celgene CNCs are committed to excellence and exceptionalism because Patients are Waiting!
***This position will be responsible for institutions within the assigned geographic area covering Minnesota, North Dakota, South Dakota and a limited scope in Iowa, including Sioux City.
Responsibilities will include:
Launch and ongoing educational support
Develop CNC Clinical Education Plans
Evaluate the effectiveness of CNC Clinical education interactions
Propel Execution of the Commercial Plan
Required Skills/Experience Education/Credentials:
Preferred Skills/Experience Education/Credentials:
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.